Filters
Biotech
Novo Nordisk Is All In On Weight Loss Drugs
Novo Nordisk (NASDAQ:NVO) has announced a new $600 million collaboration with Metaphore Biotechnologies to develop two new weight loss drug candidates.
May 10, 2024
Public Companies
Biotech
Biotech
The Startup Bringing Stem Cells Together With Artificial Intelligence
CellVoyant is leveraging artificial intelligence and computer vision to develop new stem cell based therapeutics for chronic diseases.
February 24, 2024
Biotech
Venture Capital
Startups
Biotech
BioAge Labs Is Working On A New Drug For Weight Loss
BioAge Labs is developing a new type of weight loss drug that mimics the behaviour of a molecule that is typically naturally stimulated through exercise.
February 14, 2024
Biotech
Seed Round
Startups
Venture Capital
Biotech
Loyal Doses Their First Dog In Groundbreaking Canine Longevity Clinical Trial
Biotechnology company Loyal has announced they have dosed their first ever dog in their clinical trial which aims to increase lifespan of older animals.
February 4, 2024
Biotech
General
Startups
Biotech
The Big Biotech Bets On New Obesity Treatments
Wall Street and Silicon Valley have recently been making big new bets on potential breakthrough ways to treat obesity through novel therapeutics.
February 2, 2024
Biotech
Venture Capital
Startups
Public Companies
Biotech
Alto Neuroscience Wants To Be The Next Big Biotech IPO
Los Altos, California based biotech company Alto Neuroscience has officially filed with the SEC to raise $100M USD in an IPO on the New York Stock Exchange.
January 15, 2024
IPO
Public Companies
Biotech
Biotech
BriaCell Is Bringing New Breakthroughs To Breast Cancer
BriaCell Therapeutics (NASDAQ: BCTX) has announced new positive data from their Phase II clinical trial for patients with advanced breast cancer.
December 26, 2023
Biotech
Public Companies
Biotech
This Startup Wants To Revolutionize The Inhaler
1nhaler has developed a sustainable single use medical inhaler capable of delivering multiple types of dry powder drugs to patients.
December 5, 2023
Biotech
General
Venture Capital
Startups
Discover the world's most disruptive early stage companies with 25,000+ investors.
The markets and trends that matter, made simple.
Join top talent at the world's most respected institutions, companies, and venture capital funds.